Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Podlesak Dennis, Director. Insider active across 2 companies, notably Syndax Pharmaceuticals Inc. In total, 8 disclosures have been logged. History available since 5 October 2021. The latest transaction was filed on 4 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Podlesak Dennis is Administrateur at Syndax Pharmaceuticals Inc (XNAS). He has 8 filings in total, and across the 8 sampled filings, the transactions run from 2021-10-06 to 2026-02-06, with buy volume of EUR 0 and sell volume of EUR 0; the most frequent transaction nature is Attribution.